|  Help  |  About  |  Contact Us

Search our database by keyword

Examples

  • Search this entire website. Enter identifiers, names or keywords for genes, diseases, strains, ontology terms, etc. (e.g. Pax6, Parkinson, ataxia)
  • Use OR to search for either of two terms (e.g. OR mus) or quotation marks to search for phrases (e.g. "dna binding").
  • Boolean search syntax is supported: e.g. Balb* for partial matches or mus AND NOT embryo to exclude a term

Search results 501 to 554 out of 554 for Nf2

<< First    < Previous  |  Next >    Last >>
0.029s
Type Details Score
Genotype
Symbol: Nf2/Nf2 Tg(Mpz-cre)2Brn/?
Background: involves: 129P2/OlaHsd * FVB/N
Zygosity: cn
Has Mutant Allele: true
Genotype
Symbol: Nf2/Nf2 Tg(Mx1-cre)1Cgn/?
Background: involves: 129P2/OlaHsd * C57BL/6 * CBA
Zygosity: cn
Has Mutant Allele: true
Genotype
Symbol: Nf2/Nf2 Tg(Vil1-cre)20Syr/?
Background: involves: 129P2/OlaHsd * C57BL/6 * DBA/2
Zygosity: cn
Has Mutant Allele: true
Genotype
Symbol: Cdkn2a/Cdkn2a Nf2/Nf2
Background: involves: 129P2/OlaHsd * FVB/N
Zygosity: cn
Has Mutant Allele: true
Genotype
Symbol: Nf2/Nf2 Tg(Mpz-cre)3Brn/?
Background: involves: 129P2/OlaHsd * FVB/N
Zygosity: cn
Has Mutant Allele: true
Genotype
Symbol: Nf2/Nf2 Tg(Mpz-cre)#Brn/?
Background: involves: 129P2/OlaHsd * FVB/N
Zygosity: cn
Has Mutant Allele: true
Genotype
Symbol: Nf2/Nf2 Tg(TPO-cre)1Shk/?
Background: involves: 129P2/OlaHsd * FVB/NCr
Zygosity: cn
Has Mutant Allele: true
Genotype
Symbol: Nf2/Nf2 Emx1/Emx1<+>
Background: involves: 129P2/OlaHsd * 129S2/SvPas
Zygosity: cn
Has Mutant Allele: true
Genotype
Symbol: Nf2/Nf2<+> Emx1/Emx1<+>
Background: involves: 129P2/OlaHsd * 129S2/SvPas
Zygosity: cn
Has Mutant Allele: true
Genotype
Symbol: Nf2/Nf2<+> Trp53/Trp53<+> Tg(Mpz-cre)3Brn/?
Background: involves: 129P2/OlaHsd * 129S7/SvEvBrd * FVB/N
Zygosity: cn
Has Mutant Allele: true
Genotype
Symbol: Nf2/Nf2 Trp53/Trp53<+> Tg(Mpz-cre)2Brn/?
Background: involves: 129P2/OlaHsd * 129S7/SvEvBrd * FVB/N
Zygosity: cn
Has Mutant Allele: true
Genotype
Symbol: Cdkn2a/Cdkn2a<+> Nf2/Nf2 Trp53/Trp53
Background: involves: 129P2/OlaHsd * 129S7/SvEvBrd
Zygosity: cn
Has Mutant Allele: true
Genotype
Symbol: Cdkn2a/Cdkn2a Nf2/Nf2 Trp53/Trp53
Background: involves: 129P2/OlaHsd * 129S7/SvEvBrd
Zygosity: cn
Has Mutant Allele: true
Genotype
Symbol: Nf2/Nf2 Trp53/Trp53 Tg(Mpz-cre)2Brn/?
Background: involves: 129P2/OlaHsd * 129S7/SvEvBrd * FVB/N
Zygosity: cn
Has Mutant Allele: true
Genotype
Symbol: Nf2/Nf2 Trp53/Trp53<+> Tg(Mpz-cre)3Brn/?
Background: involves: 129P2/OlaHsd * 129S7/SvEvBrd * FVB/N
Zygosity: cn
Has Mutant Allele: true
Genotype
Symbol: Nf2/Nf2 Speer6-ps1/Speer6-ps1<+>
Background: involves: 129P2/OlaHsd * C57BL/6 * DBA
Zygosity: cn
Has Mutant Allele: true
Genotype
Symbol: Nf2/Nf2 Tg(Nes-cre)1Kln/?
Background: involves: 129P2/OlaHsd * C57BL/6 * SJL
Zygosity: cn
Has Mutant Allele: true
Genotype
Symbol: Nf2/Nf2 Ptgds/Ptgds<+>
Background: involves: 129P2/OlaHsd * FVB/N
Zygosity: cn
Has Mutant Allele: true
Gene
Type: gene
Organism: human
Publication  
First Author: Basu-Roy U
Year: 2015
Journal: Nat Commun
Title: Sox2 antagonizes the Hippo pathway to maintain stemness in cancer cells.
Volume: 6
Pages: 6411
Publication
First Author: Pirazzoli V
Year: 2014
Journal: Cell Rep
Title: Acquired resistance of EGFR-mutant lung adenocarcinomas to afatinib plus cetuximab is associated with activation of mTORC1.
Volume: 7
Issue: 4
Pages: 999-1008
Publication
First Author: Fan S
Year: 2022
Journal: iScience
Title: JAM-A signals through the Hippo pathway to regulate intestinal epithelial proliferation.
Volume: 25
Issue: 5
Pages: 104316
Publication
First Author: Guo H
Year: 2020
Journal: Nat Commun
Title: Intercalated disc protein Xinβ is required for Hippo-YAP signaling in the heart.
Volume: 11
Issue: 1
Pages: 4666
Publication
First Author: Han H
Year: 2018
Journal: Mol Cell
Title: Regulation of the Hippo Pathway by Phosphatidic Acid-Mediated Lipid-Protein Interaction.
Volume: 72
Issue: 2
Pages: 328-340.e8
Publication
First Author: Gan W
Year: 2020
Journal: Nat Cell Biol
Title: LATS suppresses mTORC1 activity to directly coordinate Hippo and mTORC1 pathways in growth control.
Volume: 22
Issue: 2
Pages: 246-256
Publication
First Author: Bae JH
Year: 2022
Journal: Sci Adv
Title: Gatekeeping role of Nf2/Merlin in vascular tip EC induction through suppression of VEGFR2 internalization.
Volume: 8
Issue: 23
Pages: eabn2611
Publication
First Author: Chiasson-MacKenzie C
Year: 2023
Journal: Nat Commun
Title: Cellular mechanisms of heterogeneity in NF2-mutant schwannoma.
Volume: 14
Issue: 1
Pages: 1559
Genotype
Symbol: Nf2/Nf2 Yap1/Yap1 Speer6-ps1/Speer6-ps1<+>
Background: involves: 129P2/OlaHsd * C57BL/6 * DBA
Zygosity: cn
Has Mutant Allele: true
Genotype
Symbol: Nf2/Nf2 Yap1/Yap1<+> Speer6-ps1/Speer6-ps1<+>
Background: involves: 129P2/OlaHsd * C57BL/6 * DBA
Zygosity: cn
Has Mutant Allele: true
Genotype
Symbol: Nf2/Nf2 Ptgds/Ptgds<+> Trp53/Trp53
Background: involves: 129P2/OlaHsd * FVB/N
Zygosity: cn
Has Mutant Allele: true
Genotype
Symbol: Cdkn2a/Cdkn2a Nf2/Nf2 Ptgds/Ptgds<+>
Background: involves: 129P2/OlaHsd * FVB/N
Zygosity: cn
Has Mutant Allele: true
Genotype
Symbol: Nf2/Nf2<+> Yap1/Yap1 Emx1/Emx1<+>
Background: involves: 129P2/OlaHsd * 129S/SvEv * 129S2/SvPas
Zygosity: cn
Has Mutant Allele: true
Genotype
Symbol: Nf2/Nf2 Yap1/Yap1<+> Emx1/Emx1<+>
Background: involves: 129P2/OlaHsd * 129S/SvEv * 129S2/SvPas
Zygosity: cn
Has Mutant Allele: true
Genotype
Symbol: Nf2/Nf2 Yap1/Yap1 Emx1/Emx1<+>
Background: involves: 129P2/OlaHsd * 129S/SvEv * 129S2/SvPas
Zygosity: cn
Has Mutant Allele: true
Publication
First Author: Menges CW
Year: 2014
Journal: Cancer Res
Title: Tumor suppressor alterations cooperate to drive aggressive mesotheliomas with enriched cancer stem cells via a p53-miR-34a-c-Met axis.
Volume: 74
Issue: 4
Pages: 1261-1271
Publication
First Author: Altomare DA
Year: 2009
Journal: Proc Natl Acad Sci U S A
Title: Activated TNF-alpha/NF-kappaB signaling via down-regulation of Fas-associated factor 1 in asbestos-induced mesotheliomas from Arf knockout mice.
Volume: 106
Issue: 9
Pages: 3420-5
Publication
First Author: Nishio M
Year: 2019
Journal: FASEB J
Title: Hippo pathway controls cell adhesion and context-dependent cell competition to influence skin engraftment efficiency.
Volume: 33
Issue: 4
Pages: 5548-5560
Publication
First Author: Baudouin L
Year: 2024
Journal: Glia
Title: Antagonistic actions of PAK1 and NF2/Merlin drive myelin membrane expansion in oligodendrocytes.
Volume: 72
Issue: 8
Pages: 1518-1540
Publication
First Author: Giovannini M
Year: 2014
Journal: Neuro Oncol
Title: mTORC1 inhibition delays growth of neurofibromatosis type 2 schwannoma.
Volume: 16
Issue: 4
Pages: 493-504
Publication
First Author: Li L
Year: 2015
Journal: PLoS One
Title: Mediator Subunit Med28 Is Essential for Mouse Peri-Implantation Development and Pluripotency.
Volume: 10
Issue: 10
Pages: e0140192
Publication
First Author: Jeong W
Year: 2024
Journal: EMBO Rep
Title: Retinoic acid-induced protein 14 links mechanical forces to Hippo signaling.
Volume: 25
Issue: 9
Pages: 4033-4061
Publication
First Author: Bijlsma EK
Year: 1993
Journal: Genes Chromosomes Cancer
Title: Regional fine mapping of the beta crystallin genes on chromosome 22 excludes these genes as physically linked markers for neurofibromatosis type 2.
Volume: 8
Issue: 2
Pages: 112-8
Publication
First Author: Chung DC
Year: 1998
Journal: Cancer Res
Title: Localization of putative tumor suppressor loci by genome-wide allelotyping in human pancreatic endocrine tumors.
Volume: 58
Issue: 16
Pages: 3706-11
Publication
First Author: Messerli SM
Year: 2002
Journal: Neoplasia
Title: Detection of spontaneous schwannomas by MRI in a transgenic murine model of neurofibromatosis type 2.
Volume: 4
Issue: 6
Pages: 501-9
Publication
First Author: Stemmer-Rachamimov AO
Year: 2004
Journal: Cancer Res
Title: Comparative pathology of nerve sheath tumors in mouse models and humans.
Volume: 64
Issue: 10
Pages: 3718-24
Publication
First Author: Aavikko M
Year: 2012
Journal: Am J Hum Genet
Title: Loss of SUFU function in familial multiple meningioma.
Volume: 91
Issue: 3
Pages: 520-6
Publication
First Author: Menges CW
Year: 2012
Journal: Mol Cancer Res
Title: Group I p21-activated kinases (PAKs) promote tumor cell proliferation and survival through the AKT1 and Raf-MAPK pathways.
Volume: 10
Issue: 9
Pages: 1178-88
Publication
First Author: Moroishi T
Year: 2015
Journal: Genes Dev
Title: A YAP/TAZ-induced feedback mechanism regulates Hippo pathway homeostasis.
Volume: 29
Issue: 12
Pages: 1271-84
Publication
First Author: Sementino E
Year: 2022
Journal: Mol Cancer Res
Title: Inactivation of p21-Activated Kinase 2 (Pak2) Inhibits the Development of Nf2-Deficient Tumors by Restricting Downstream Hedgehog and Wnt Signaling.
Volume: 20
Issue: 5
Pages: 699-711
Genotype
Symbol: Hras/Hras Nf2/Nf2 Tg(TPO-cre)1Shk/?
Background: involves: 129P2/OlaHsd * 129S6/SvEvTac * Black Swiss * C57BL/6 * FVB/NCr
Zygosity: cn
Has Mutant Allele: true
Publication
First Author: Toledo A
Year: 2018
Journal: PLoS One
Title: Neurofibromatosis type 2 tumor suppressor protein is expressed in oligodendrocytes and regulates cell proliferation and process formation.
Volume: 13
Issue: 5
Pages: e0196726
Publication
First Author: Rice JM
Year: 2004
Journal: Toxicol Appl Pharmacol
Title: Causation of nervous system tumors in children: insights from traditional and genetically engineered animal models.
Volume: 199
Issue: 2
Pages: 175-91
Publication
First Author: Juriloff DM
Year: 2000
Journal: Mamm Genome
Title: Gaping lids, gp, a mutation on centromeric chromosome 11 that causes defective eyelid development in mice.
Volume: 11
Issue: 6
Pages: 440-7
Publication
First Author: Gerhard DS
Year: 2004
Journal: Genome Res
Title: The status, quality, and expansion of the NIH full-length cDNA project: the Mammalian Gene Collection (MGC).
Volume: 14
Issue: 10B
Pages: 2121-7